Introduction
Hypertension is an increasingly important public health challenge throughout the world among the cardiovascular diseases 1 
Materials and Methods
This prospective observational study was carried out in the Department of Physiology of Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, from July 2012 to June 2013. Hundred newly diagnosed hypertensive patients aged 30-55 years were selected as study group. Age, sex and BMI matched 50 apparently healthy normotensive subjects were also studied as control (group A). Based on treatment, these study subjects were divided into two groups; B1 and B2. B1 included 50 patients who received amlodipine 5mg daily and B2 included 50 patients who received atenolol 50mg daily. Lung function tests were done in both B1 and B2 groups before taking medication, after 3 months of medication and after 6 months of medication. Basing on the duration of the treatment group B1 was named as B1 a (newly diagnosed hypertensive patients before treatment), B1 b (after 3 months of medication with amlodipine) and B1 c (after 6 months of medication with amlodipine). Similarly subjects of group B2 were named as B2 a (newly diagnosed hypertensive patients before treatment), B2 b (after 3 months of medication with atenolol) and B2 c (after 6 months of medication with atenolol). These patients were selected from the Out Patient Department of Cardiology, BSMMU.
Subjects with history of acute or chronic lung and chest wall disease e.g. pneumonia, tuberculosis, asthma, COPD, malignancy etc, history of coronary heart disease, diabetes mellitus, alcohol/tobacco users and smokers were excluded from the study. After random selection of the subjects a detail personal, medical, family, socioeconomic, occupational and drug history were recorded in a preformed questionnaire and thorough physical examinations were done and documented. For the assessment of lung function FVC, FEV 1 and PEFR were measured with a computer based Spirometer.
Then all the patients were requested to attend the Department of Physiology of BSMMU, again after 3 months and after 6 months of antihypertensive medication, to have the assessment of the above mentioned study variables. For statistical analysis independent sample't' test and paired sample't' test were performed by using SPSS (Statistical Package for Social Sciences) for windows version 16.0 as applicable. P value <0.05 was accepted as level of significance.
Results
The mean of the percentages of predicted values of FVC, FEV 1 and PEFR were significantly lower in group B1 a , B1 b and B1 c respectively than those of control. In addition, the mean percentage of predicted values of FVC, FEV 1 and PEFR were significantly increased in group B1 b and B1 c in comparison to their corresponding base line values of group B1 a ( Table-I) . (Table-II) . 10 . The exact mechanisms involved for the decrement of lung functions in hypertension and improvement after treatment with amlodipine but not with atenolol in hypertensive groups of present study could not be elucidated from this type of study. However, it is assumed that all the above mentioned mechanisms may influence the degree of deterioration of these variables in hypertension patients and improvement after treatment with amlodipine but not with atenolol.
Conclusion
The ventilatory variables decrease in newly diagnosed patients with hypertension and lung function status improves after treatment with amlodipine but further decreases after treatment with atenolol. Apart from the suggested mechanism by several researchers these decrement may be associated with silent pulmonary disorders without presenting any pulmonary symptoms.
